Video-on-Demand Library

Play

PSI EIWG Webinar: Estimands in Oncology - How and Why

02 June 2021

You will be guided through a case study (CheckMate 037) and interactively deepen the knowledge to gain hands-on experience in developing estimands. You will be introduced to the background and disease context of the case study, the concept of an estimand, and important clinical events (increased dropout rate and crossover therapy) that occurred in the trial and affected interpretation of the results. Using non-technical language and clear graphical presentation of the concepts, you will experience how the estimand framework provides a common language to describe the diversity of patient journeys and why it is important to address the right question in clinical trials. Target audience (no prior knowledge in oncology or of estimands required): Clinicians, Investigators, Regulatory Experts, Medical Writers, Ethics Committees, Statisticians.

The targeted learning outcomes are as follows: - Recognize the benefits of following the estimand framework (ICH E9 (R1) addendum) in the context of a clinical trial, in order to: - have a common language to describe the diversity of patient journeys - address the right question in clinical trials - Be able to construct an estimand, including identification of relevant intercurrent events and application of relevant strategies to address them - Gain insights from a cross-industry international working group on estimands in oncology Presented by members of the Estimands in Oncology special interest group www.oncoestimand.org 

Contents
05:33 Learning Outcomes
06:30 Introduction to the case study
15:55 Intermezzo - Comic
17:20 Estimands in Oncology - How and Why
     17:20 ICH E9 (R1) Estimand Framework
     21:40 Five Components of an Estimand
     25:15 Five Strategies for Intercurrent Events
42:43 Revisiting the case study
     45:00 Estimand for the primary analysis
     47:21 Estimand for the post-hoc analysis
49:20 Interactive quiz with Q&A
1:18:40 Concluding Remarks
1:20:30 General Q&A
 

Part of Collection(s)

Topic(s)

Upcoming Events

PSI VisSIG Wonderful Wednesday Webinar Series (2023)

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Webinar: Application of Bayesian Methods in Confirmatory Trials

This webinar consists of three presentations providing examples of where Bayesian methods have been used within confirmatory settings.

PSI Launch & Lifecycle SIG Webinar: Do you want to stay single? Considerations on single arm trials in the post-regulatory space

We will present the most frequently asked questions in the post-marketing space, the reasons why SATs are not able to address these questions, and how statisticians might reasonably influence decision makers to consider alternatives.

PSI Training Course: Missing Data

This course will introduce participants to the key concepts and methods relevant for analysing clinical trials when some data are missing.

PSI Scientific Meeting: Patient-focused drug development

The meeting will consider the importance of patient-centric input into regulatory and HTA decision-making discussing the latest developments in the field and presenting industry examples.

PSI Book Club

The next book we are reading is "The 7 Habits of Highly Effective People" by Stephen R. Covey. This is a classic in the personal development genre.

PSI Pre-Clinical SIG Webinar: Adjusting Experimental & Statistical Approaches throughout Preclinical development pathways

PD Dr. Tölch will present a framework to foster efficient evidence generation in preclinical experiments and will illustrate the proposed approach using examples from various projects. This will be followed by Q&A.

PSI Vaccine SIG Webinar: A Vaccine Statistician’s Journey in Designing and Analyzing Monoclonal Antibody Studies

Our speaker will share her experience in extending/innovating methodology and concepts developed in vaccine statistics to the analyses of pre-efficacy and efficacy trials of monoclonal antibodies.

PSI Careers - MEDMathS: Medicine Empowered by Data, Maths and Statistics

A careers talk about medical statistics and how it plays a crucial role in developing new medicines

PSI Journal Club: Bayesian Approaches in Efficacy and Safety

Please join us to hear Kristian Brock and Ying Yuan present their recent work for our next Journal Club webinar, as sponsored by Wiley.

PSI Training Course: Sample Sizing for Clinical Trials

This course describes calculations for sample size estimation in the design of clinical trials. It will highlight how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.

PSI Biomarkers SIG Webinar: A promising adaptive biomarker-based design strategy for early phase and machine learning as an enabler of precision medicine!

In this webinar, you will get to know how an innovative adaptive design can increase the probability of success of your early phase clinical trial as well as hear the latest and greatest of the Machine Learning workstream from the Biomarkers ESIG.

PSI Scientific Meeting: Master Protocols - Industry, Academic, and Regulatory Perspectives

This one-day event will establish a forum to engage with colleagues from a diverse range of backgrounds who are actively working on effective master protocol design, analysis, and execution.

PSI Medical Statistics Careers Event

This event is aimed at students with an interest in the field of Medical Statistics, for example within pharmaceuticals, healthcare and/or medical research.

PSI Career Young Virtual Meet (Q4 2023)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Webinar(s): Causal inference in Clinical Trials

Over the course of two sessions, a panel of 8 esteemed speakers will give an introduction to the topic, followed by a presentation of case studies & interactive panel discussion.